Abstract
Major ethnic and geographic differences exist for insulin-dependent diabetes mellitus (IDDM) around the world.1 The disease is most common in people of European descent (Europids) with the highest reported incidence in Scandinavian countries,1,2 particularly in Finland where the incidence exceeds 30 cases/annum per 100,000 population.3 The lowest incidence rates are in Asia, notably Korea at 0.5 cases/annum1 with low rates in Japan3 and China as well.4 These geographic and ethnic differences are possibly due to variations in environmental risk determinants, although genetic differences may also be operative.5
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
M. Rewers, R.E. LaPorte, H. King, J. Tuomilehto, Trends in the prevalence and incidence of diabetes: Insulin-dependent diabetes mellitus in childhood, World Hlth Stat Q. 41:179 (1988).
A. Green, E.A.M. Gale, C.C. Patterson, Incidence of childhood onset insulin-dependent diabetes mellitus: The EURODIAB ACE study, Lancet 339:905 (1992).
J. Tuomilehto, M. Rewers, A. Reunanen, P. Lounamaa, R. Lounamaa, E. Tuomilehto-Wolf, H.K. Åkerblom, Increasing trends in Type I (insulin-dependent) diabetes mellitus in childhood in Finland. Analysis of age, calendar time and birth cohort effects during 1965 to 1984, Diabetologia 34:282 (1991).
M-Z. Bao, J.-X. Wang, J.S. Dorman, M. Trucco, HLA-DQß non-asp-57 allele and incidence of diabetes in China and the USA, Lancet 2:497 (1989).
J.S. Dorman, R.E. LaPorte, R.A. Stone, M. Trucco, Worldwide differences in the incidence of Type I diabetes are associated with amino acid variation at position 57 of the HLA-DQß chain, Proc Natl Acad Sci. USA 87:7370 (1990).
G.F. Bottazzo, A. Florin-Christensen, D. Doniach, Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies, Lancet 2:1279 (1974).
J.P. Palmer, CM. Asplin, P. Clemons, K. Lyon, O. Iatpati, P. Raghu, T.L. Paquette, Insulin antibodies in insulin-dependent diabetes before insulin treatment, Science 222:1337 (1983).
S. Baekkeskov, J.H. Nielsen, B. Marner, T. Bilde, J. Ludvigsson, A. Lernmark, Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins, Nature, 298:167 (1982).
S. Baekkeskov, H-J. Aanstoot, S. Christgau, A. Reetz, M. Solimena, M. Cascalho, F. Folli, H. Richter-Olesen, P-D. Camilli, Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase, Nature 347:151 (1990).
W. Hagopian A. Lernmark, Autoimmune diabetes mellitus, in: “The Autoimmune Diseases II,” N.R. Rose, and I.R. Mackay, eds., Academic Press, Orlando, (1992).
R. Lipton R.E. LaPorte, Epidemiology of islet cell antibodies, Epidemiol Rev. 11:182 (1989).
J.K. Karjalainen, Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease, Diabetes 39:1144 (1990).
D.G. McLarty, I. Athaide, G.F. Bottazzo, A.M.B. Swai, K.G.M.M. Alberti, Islet cell antibodies are not specifically associated with insulin-dependent diabetes in Tanzanian Africans, Diabetes Res Clin Practice 9:219 (1990).
A. Elamin, M.I.A. Omer, T. Tuvemo, Islet cell antibodies and endogenous insulin secretion in Sudanese diabetic children, Diabetes Res Clin Practice 16:91 (1992).
J.P. Palmer D.K. McCulloch, Prediction and Prevention of IDDM — 1991, Diabetes 40:943 (1991).
R. Lendrum, G. Walker, D.R. Gamble, Islet cell antibodies in juvenile diabetes mellitus of recent onset, Lancet 1:880 (1975).
A.G. Ziegler, R.D. Herskowitz, R.A. Jackson, J.S. Soeldner, G.S. Eisenbarth, Predicting Type I diabetes, Diabetes Care 13:762 (1990).
S. Baekkeskov, J.K. Kristensen, S. Srikanta, G.J. Bruining, T. Mandrup-Poulsen, C. DeBeaufort, J.S. Soeldner, G. Eisenbarth, F. Lindgren, A. Lernmark, Antibodies to a M 64,000 human islet cell antigen precede the clinical onset of insulin-dependent diabetes, J Clin Invest. 4 79:926 (1987).
M.A. Atkinson, N.K. Maclaren, D.W. Scharp, P.E. Lacy, W.J. Riley, 64,000 M1 autoantibodies as predictors of insulin-dependent diabetes, Lancet 335:1357 (1990).
M.J. Rowley, I.R. Mackay, Q-Y. Chen, W.J. Knowles, P. Zimmet, Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus, Diabetes 41:548 (1992).
Q-Y. Chen, G.C. Byrne, T. Jones, T. Tuomi, I.R. Mackay, M.J. Rowley, W.J. Knowles, P.Z. Zimmet, Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first degree relatives, Pediatr Res 34:785 (1993).
S.W. Serjeantson, B.D. Tait, P. Chiewslip, E. Gazit, B.R. Hawkins, M.R.J. Kohonen-Corish, H.K. Lee, D. Propert, T.O. Yoshida, Insulin-dependent diabetes mellitus workshop: Joint Report, in: “HLA in Asia-Oceania 1986,” M. Aizawa, T. Natori, A. Wakisaka, Y. Konoeda, eds., Hokkaido University Press, Sapporo (1986).
National Diabetes Data Group, Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance, Diabetes 28:1039 (1979).
W. Knowles, P. Zimmet, M. Rowley, I. Mackay, Q-Y. Chen, L. Chapman, G. Senator, S. Serjeantson, The epidemiology of antibodies to glutamic acid decarboxylase: Presence and levels in insulin-dependent diabetes mellitus in Europid and Asian subjects, Diabetes 41(suppl. 1): 127A (Abstract), (1992).
S.W. Serjeantson, M.J. Kohonen-Corish, M.J. Rowley, I.R. Mackay, P. Zimmet, Antibodies to glutamic acid decarboxylase are associated with HLA-DR genotypes in both Australian and Asians with insulin-dependent diabetes mellitus, Diabetologia 35:996 (1992).
M.J. Clare-Salzler, A.J. Tobin, D.L. Kaufman, Glutamate decarboxylase: An autoantigen in IDDM, Diabetes Care 15:132 (1992).
M.I. Harris, P. Zimmet, Classification of diabetes mellitus and other categories of glucose intolerance, in: “The International Textbook of Diabetes Mellitus,” H. Keen, R. DeFronzo, K.G.M.M. Alberti, P. Zimmet, eds., John Wiley, London (1992).
P. Zimmet, H. King, Classification and diagnosis of diabetes mellitus, in: “The Diabetes Annual/3,” K.G.M.M. Alberti, L.P. Krall, eds., Elsevier, Amsterdam (1987).
L. Groop, A. Miettinen, P.H. Groop, S. Meri, S. Koskimies, G.F. Bottazzo, Organ-specific auto-immunity and HLA-DR antigens as markers for ß-cell destruction in patients with Type II diabetes, Diabetes 37:99 (1988).
B.D. Rhee, K-U. Lee, S.Y. Kim, B.Y. Cho, H.K. Lee, C-S. Koh, H.K. Min, Some immunogenetic and clinical aspects of Type I diabetes in Korea, in: “Recent Advances in Insulin Therapy,” T.H. Lee, K.B. Huh, S. Baba, eds., Elsevier, Amsterdam (1990).
L.C. Groop, G.F. Bottazzo, D. Doniach, Islet cell antibodies identify latent Type I diabetes in patients aged 35–75 years at diagnosis, Diabetes 35:237 (1986).
American Diabetes Association Position statement: Prevention of Type I diabetes mellitus, Diabetes 39:1151 (1990).
P.Z. Zimmet, M.J. Rowley, I.R. Mackay, W.J. Knowles, Q.-Y. Chen, L.H. Chapman, S.W. Serjeantson, The ethnic distribution of antibodies to glutamic acid decarboxylase: Presence and levels in insulin-dependent diabetes mellitus in Europid and Asian Subjects, J Diab Comp 7:1 (1993).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Zimmet, P., Mackay, I.R., Rowley, M., Knowles, W., Serjeantson, S.W. (1994). Geographic Differences in Antibodies to Glutamic Acid Decarboxylase in Insulin-Dependent Diabetes Mellitus. In: Dorman, J.S. (eds) Standardization of Epidemiologic Studies of Host Susceptibility. NATO ASI Series, vol 270. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1213-8_19
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1213-8_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1215-2
Online ISBN: 978-1-4899-1213-8
eBook Packages: Springer Book Archive